Homeopathic Drug Product Safety, Quality, and Transparency Act

Hozzl · 2026-02-02T15:00:00Z

Explore the details of House Bill 7050 Homeopathic Drug Product Safety, Quality, and Transparency Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/2/2026, 3:00 PM

Summary of Bill HR 7050

The Homeopathic Drug Product Safety, Quality, and Transparency Act, designated as H.R. 7050 in the 119th Congress and introduced on January 14, 2026, aims to address safety, quality, and transparency issues related to homeopathic drug products. The bill likely includes provisions to enhance the regulation and oversight of these products to ensure consumer safety and efficacy. Specific directives may involve increased product testing requirements, labeling standards, or reporting mechanisms to provide more comprehensive information to the public regarding the use and effects of homeopathic remedies.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 7050

Bill HR 7050 is currently in the status of Bill Introduced since January 14, 2026. Bill HR 7050 was introduced during Congress 119 and was introduced to the House on January 14, 2026. Bill HR 7050's most recent activity was Referred to the House Committee on Energy and Commerce. as of January 14, 2026